NorthStar Trial Analysis at ELCC 2026: Local Consolidative Therapy in EGFR-Mutant NSCLC
oncodaily - The management of metastatic EGFR-mutant non-small cell lung cancer (NSCLC) has been transformed by the introduction of third-generation EGFR tyrosine kinase inhibitors, particularly osimertinib. While systemic therapy achieves meaningful disease […]
AI Summary: ELCC 2026 brought together clinicians and investigators to present pivotal lung‑cancer studies, including localized consolidative therapy, SBRT sequencing with immunotherapy, and trials addressing under‑represented KRAS and EGFR populations. The conference highlighted survival and tumor‑control signals, networked international collaborators, and emphasized real‑world applicability — proving once again that conferences are where hope meets peer review.
- At ELCC: late‑breaking trials reshaping clinical practice (6)
- OTHER: misc lung oncology studies, regulatory and surgical updates (8)
- Precision push: molecular testing, KRAS degraders, ADC collaborations advancing care (6)
- Voices from ELCC: clinicians share breakthroughs and practical takeaways (17)
- All Other Stories
At ELCC: late‑breaking trials reshaping clinical practice
OTHER: misc lung oncology studies, regulatory and surgical updates
Precision push: molecular testing, KRAS degraders, ADC collaborations advancing care
Voices from ELCC: clinicians share breakthroughs and practical takeaways
All Other Stories
Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61
Related Stories
Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128
Phase I lung cancer trials consolidating at top-performing U.S. sites / 5 wks
CAR-PRISM trial shows BCMA CAR T effective in high-risk smoldering myeloma / 5 wks
Long‑term immunotherapy appears safe for alveolar soft part sarcoma / 5 wks
Zongertinib emerges as first-line therapy for HER2‑mutant NSCLC / 6 wks
Antoni Ribas receives AACR‑Margaret Foti Award for leadership / 7 wks
Romiplostim reduces chemotherapy‑induced thrombocytopenia and prevents recurrence / 2 months
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma / 2 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Mergers and Acquisitions, Corporate Takeover, Adolescent Health, Alzheimer's disease and look for the RSS link.
StackHealth Time Machine